Flagship Ventures Fund IV General Partner LLC, 10% Owner at Evelo Biosciences, Inc. (EVLO), bought 14,903,393 shares at $16.00 ($4.5M) on 2018-05-11, disclosed to the SEC on 2018-05-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 14,622,143 | $0 | 0.0% |
| 2 | $16.00 | 281,250 | $4.5M | 100.0% |
| Total | $0.30 avg | 14,903,393 | $4.5M | 100% |
| Filing → |